Clinical trial
Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Prospective RWE Study (MYLUNG Consortium: Part 2)
NCT05644808 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Prospective RWE Study (MYLUNG Consortium: Part 2)
- Lead sponsor
- US Oncology Research
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- December 29, 2020
- Completion date
- December 31, 2027
- Enrollment
- 1,002 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.